Tenax Therapeutics (TENX) Granted Notice of Allowance for U.

Tenax Therapeutics (TENX) Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in PH-HFpEF

Tenax Therapeutics (TENX) Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in PH-HFpEF
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Finland , United States , Ukraine , American , Chris Giordano , John Mullalymanaging Directorlifesci , Trademark Office , American Heart Association Science Advisory , Nasdaq Stock Market , Tenax Therapeutics Inc , Nasdaq , Orion Corporation , United States Patent , Tenax Therapeutic , Tenax Therapeutic Chief Executive Officer , Tenax Therapeutics , Stuart Rich , Chief Medical Officer , American Heart Association Science , Clinical Implications , Pulmonary Hypertension , Heart Failure With Preserved Ejection Fraction , Science Advisory From , American Heart Association , North American , Tenax Therapeutic Phase , John Mullalymanaging Directorlifesci Advisors ,